ReShape Lifesciences Stock Quote RSLS - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

0.1692

Bid

0.1653

Ask

0.1732

Volume

67,419

0.1652 Day's Range 0.1731

0.1414 52 Week Range 2.798

Market Cap

3.988M

Previous Close

0.1669

Open

0.1685

Last Trade

0.167

Last Trade Time

09:51:48

Financial Volume

$ 11,424

VWAP

0.169454

Average Volume (3m)

511,856

Shares Outstanding

23,457,047

Dividend Yield

PE Ratio

-0.35

Earnings Per Share (EPS)

-0.49

Revenue

8.68M

Net Profit

-11.39M

Reshape Lifesciences Inc is a developer of minimally invasive medical devices to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, the ReShape Vest, an investigational device, to help treat more patients with obesity, a... Reshape Lifesciences Inc is a developer of minimally invasive medical devices to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, the ReShape Vest, an investigational device, to help treat more patients with obesity, and ReShapeCare, a virtual coaching program delivered through an app. Show more

Sector

Surgical,med Instr,apparatus

Industry

Surgical,med Instr,apparatus

Website

www.reshapelifesciences.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

ReShape Lifesciences Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker RSLS. The last closing price for ReShape Lifesciences was $0.17. Over the last year, ReShape Lifesciences shares have traded in a share price range of $ 0.1414 to $ 2.798.

ReShape Lifesciences currently has 23,457,047 shares outstanding. The market capitalization of ReShape Lifesciences is $3.99 million. ReShape Lifesciences has a price to earnings ratio (PE ratio) of -0.35.

ReShape Lifesciences® Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Update

Completed First Surgeries With Next-Generation Lap-Band® 2.0 FLEX 2024 Operating Expenses Expected to Decrease by more than 50% Compared to 2023; Reaffirming Commitment to Profitability...

ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System

IRVINE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that the...

ReShape Lifesciences® Provides Update on 2024 Cost Reduction Plan and Reorganization to Prioritize Commercialization of Lap-Band® 2.0 FLEX

2024 Operating Expenses Expected to Decrease by 55.4% Compared to 2023 Company Reaffirms Commitment to Profitability High Priority Search for Synergistic M&A Partner Continues IRVINE, Calif...

Form 8-K - Current report

ReShape Lifesciences® Announces First Surgeries Utilizing Next-Generation Lap-Band® 2.0 FLEX

FLEX Technology Designed to Enhance the Patient Experience Surgeon Training Underway for the Initial Launch of the Lap-Band® 2.0 FLEX IRVINE, Calif., Feb. 22, 2024 (GLOBE NEWSWIRE) -- ReShape...

ReShape Lifesciences® Conducts Bariatric Fellows Training for its Lap-Band® System, Highlighting the Next-Generation Lap-Band® 2.0 FLEX

IRVINE, Calif., Jan. 24, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that...

Form 8-K - Current report

Form 3 - Initial statement of beneficial ownership of securities

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.0082	5.09316770186	0.161	0.177	0.16	204978	0.16686899	CS
4	-0.0133	-7.28767123288	0.1825	0.209	0.158	342965	0.17199409	CS
12	-0.0438	-20.5633802817	0.213	0.2245	0.1414	511856	0.17278012	CS
26	-0.0318	-15.8208955224	0.201	0.59	0.1414	3614025	0.31190874	CS
52	-2.5808	-93.8472727273	2.75	2.798	0.1414	2297111	0.34731628	CS
156	-474.8308	-99.9643789474	475	475	0.1414	1514733	76.03832781	CS
260	-474.8308	-99.9643789474	475	475	0.1414	1514733	76.03832781	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CYNCYNGN Inc	$ 0.2337 (93.14%)	143.45M
OPRTOportun Financial Corporation	$ 3.26 (44.89%)	776.7k
PALIPalisade Bio Inc	$ 7.03 (42.60%)	10.75M
PEGYPineapple Energy Inc	$ 0.0653 (42.58%)	101.73M
SMFLSmart for Life Inc	$ 5.95 (36.78%)	9.51M
GWAVGreenwave Technology Solutions Inc	$ 0.0655 (-48.14%)	15.65M
LICNLichen China Limited	$ 0.5249 (-45.82%)	446.81k
ABEOAbeona Therapeutics Inc	$ 4.15 (-43.61%)	988.56k
TWGTop Wealth Group Holding Ltd	$ 2.0201 (-22.30%)	373.89k
MLECMoolec Science SA	$ 1.9394 (-21.48%)	1.4M
CYNCYNGN Inc	$ 0.2337 (93.14%)	143.45M
PEGYPineapple Energy Inc	$ 0.0653 (42.58%)	101.73M
AGBAAGBA Group Holding Ltd	$ 2.6905 (7.62%)	17.29M
GWAVGreenwave Technology Solutions Inc	$ 0.0655 (-48.14%)	15.65M
SQQQProShares UltraPro Short QQQ	$ 12.225 (-1.96%)	15.33M